Chinese healthcare companies hit COVID jackpot with home-test kits

Overseas sales boom as omicron rages, but pandemic's end will clip windfall

2022-02-18.Antigen.JPG

The omicron variant has sparked huge demand for rapid antigen testing kits. © Reuters

CISSY ZHOU, Nikkei staff writer

HONG KONG -- Andon Health suffered through years of losses until the Chinese medical device maker shifted to exporting COVID-19 home testing kits, unleashing a cash windfall that is also boosting the fortunes of other mainland health care operators.

Sponsored Content

About Sponsored ContentThis content was commissioned by Nikkei's Global Business Bureau.